Are iron oxide nanoparticles safe? Current knowledge and future perspectives

Detalhes bibliográficos
Autor(a) principal: Valdiglesias, V
Data de Publicação: 2016
Outros Autores: Fernández-Bertólez, N, Kiliç, G, Costa, C, Costa, S, Fraga, S, Bessa, MJ, Pásaro, E, Teixeira, JP, Laffon, B
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10216/114773
Resumo: Due to their unique physicochemical properties, including superparamagnetism, iron oxide nanoparticles (ION) have a number of interesting applications, especially in the biomedical field, that make them one of the most fascinating nanomaterials. They are used as contrast agents for magnetic resonance imaging, in targeted drug delivery, and for induced hyperthermia cancer treatments. Together with these valuable uses, concerns regarding the onset of unexpected adverse health effects following exposure have been also raised. Nevertheless, despite the numerous ION purposes being explored, currently available information on their potential toxicity is still scarce and controversial data have been reported. Although ION have traditionally been considered as biocompatible - mainly on the basis of viability tests results - influence of nanoparticle surface coating, size, or dose, and of other experimental factors such as treatment time or cell type, has been demonstrated to be important for ION in vitro toxicity manifestation. In vivo studies have shown distribution of ION to different tissues and organs, including brain after passing the blood-brain barrier; nevertheless results from acute toxicity, genotoxicity, immunotoxicity, neurotoxicity and reproductive toxicity investigations in different animal models do not provide a clear overview on ION safety yet, and epidemiological studies are almost inexistent. Much work has still to be done to fully understand how these nanomaterials interact with cellular systems and what, if any, potential adverse health consequences can derive from ION exposure.
id RCAP_32d7822814a162bc201de5b808cb1ac6
oai_identifier_str oai:repositorio-aberto.up.pt:10216/114773
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str
spelling Are iron oxide nanoparticles safe? Current knowledge and future perspectivesIron oxide nanoparticlesIn vivo studiesIn vitro studiesDue to their unique physicochemical properties, including superparamagnetism, iron oxide nanoparticles (ION) have a number of interesting applications, especially in the biomedical field, that make them one of the most fascinating nanomaterials. They are used as contrast agents for magnetic resonance imaging, in targeted drug delivery, and for induced hyperthermia cancer treatments. Together with these valuable uses, concerns regarding the onset of unexpected adverse health effects following exposure have been also raised. Nevertheless, despite the numerous ION purposes being explored, currently available information on their potential toxicity is still scarce and controversial data have been reported. Although ION have traditionally been considered as biocompatible - mainly on the basis of viability tests results - influence of nanoparticle surface coating, size, or dose, and of other experimental factors such as treatment time or cell type, has been demonstrated to be important for ION in vitro toxicity manifestation. In vivo studies have shown distribution of ION to different tissues and organs, including brain after passing the blood-brain barrier; nevertheless results from acute toxicity, genotoxicity, immunotoxicity, neurotoxicity and reproductive toxicity investigations in different animal models do not provide a clear overview on ION safety yet, and epidemiological studies are almost inexistent. Much work has still to be done to fully understand how these nanomaterials interact with cellular systems and what, if any, potential adverse health consequences can derive from ION exposure.20162016-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10216/114773eng0946-672X10.1016/j.jtemb.2016.03.017Valdiglesias, VFernández-Bertólez, NKiliç, GCosta, CCosta, SFraga, SBessa, MJPásaro, ETeixeira, JPLaffon, Binfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-07-26T15:02:29ZPortal AgregadorONG
dc.title.none.fl_str_mv Are iron oxide nanoparticles safe? Current knowledge and future perspectives
title Are iron oxide nanoparticles safe? Current knowledge and future perspectives
spellingShingle Are iron oxide nanoparticles safe? Current knowledge and future perspectives
Valdiglesias, V
Iron oxide nanoparticles
In vivo studies
In vitro studies
title_short Are iron oxide nanoparticles safe? Current knowledge and future perspectives
title_full Are iron oxide nanoparticles safe? Current knowledge and future perspectives
title_fullStr Are iron oxide nanoparticles safe? Current knowledge and future perspectives
title_full_unstemmed Are iron oxide nanoparticles safe? Current knowledge and future perspectives
title_sort Are iron oxide nanoparticles safe? Current knowledge and future perspectives
author Valdiglesias, V
author_facet Valdiglesias, V
Fernández-Bertólez, N
Kiliç, G
Costa, C
Costa, S
Fraga, S
Bessa, MJ
Pásaro, E
Teixeira, JP
Laffon, B
author_role author
author2 Fernández-Bertólez, N
Kiliç, G
Costa, C
Costa, S
Fraga, S
Bessa, MJ
Pásaro, E
Teixeira, JP
Laffon, B
author2_role author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Valdiglesias, V
Fernández-Bertólez, N
Kiliç, G
Costa, C
Costa, S
Fraga, S
Bessa, MJ
Pásaro, E
Teixeira, JP
Laffon, B
dc.subject.por.fl_str_mv Iron oxide nanoparticles
In vivo studies
In vitro studies
topic Iron oxide nanoparticles
In vivo studies
In vitro studies
description Due to their unique physicochemical properties, including superparamagnetism, iron oxide nanoparticles (ION) have a number of interesting applications, especially in the biomedical field, that make them one of the most fascinating nanomaterials. They are used as contrast agents for magnetic resonance imaging, in targeted drug delivery, and for induced hyperthermia cancer treatments. Together with these valuable uses, concerns regarding the onset of unexpected adverse health effects following exposure have been also raised. Nevertheless, despite the numerous ION purposes being explored, currently available information on their potential toxicity is still scarce and controversial data have been reported. Although ION have traditionally been considered as biocompatible - mainly on the basis of viability tests results - influence of nanoparticle surface coating, size, or dose, and of other experimental factors such as treatment time or cell type, has been demonstrated to be important for ION in vitro toxicity manifestation. In vivo studies have shown distribution of ION to different tissues and organs, including brain after passing the blood-brain barrier; nevertheless results from acute toxicity, genotoxicity, immunotoxicity, neurotoxicity and reproductive toxicity investigations in different animal models do not provide a clear overview on ION safety yet, and epidemiological studies are almost inexistent. Much work has still to be done to fully understand how these nanomaterials interact with cellular systems and what, if any, potential adverse health consequences can derive from ION exposure.
publishDate 2016
dc.date.none.fl_str_mv 2016
2016-01-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10216/114773
url http://hdl.handle.net/10216/114773
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 0946-672X
10.1016/j.jtemb.2016.03.017
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1777304326447824896